Management of Resistant Hypertension in Dialysis Patients

Introduction to Resistant Hypertension Management

The American Society of Nephrology recommends aggressively reassessing and optimizing volume status through strict sodium restriction, probing for true dry weight with intensified ultrafiltration, and using low-sodium dialysate to manage resistant hypertension in dialysis patients 1, 2, 3

The European Renal Association recommends verifying accurate blood pressure measurement using 44-hour interdialytic ambulatory blood pressure monitoring or home blood pressure monitoring to exclude pseudoresistance 1, 2, 3, 5, 6
The International Society of Nephrology suggests assessing for intradialytic hypertension patterns, where an SBP increase >10 mm Hg from pre- to post-dialysis in at least 4 of 6 consecutive treatments indicates volume excess and warrants immediate dry weight reassessment 1, 2, 3, 5, 6

The National Kidney Foundation recommends implementing strict dietary sodium restriction to <1500 mg/day with formal dietary counseling to manage volume overload 1, 2, 3
The American Heart Association suggests using low-sodium dialysate to facilitate volume removal 1, 2, 3
The European Society of Cardiology recommends probing for true dry weight through gradual ultrafiltration intensification, even if this causes transient intradialytic symptoms 1, 2, 3

The American College of Cardiology recommends adding or optimizing ACE inhibitors/ARBs, such as benazepril or fosinopril, as they reduce left ventricular hypertrophy and are associated with decreased mortality 1, 2, 5, 6
The European Society of Hypertension suggests adding or optimizing beta-blockers, particularly carvedilol or labetalol, especially if the patient has prior myocardial infarction or coronary artery disease, as they provide mortality benefit 1, 2, 5, 6

The International Society of Hypertension recommends adding low-dose spironolactone (12.5-25 mg daily) as the preferred fourth agent, with close monitoring for hyperkalemia, for refractory cases 1, 2, 5, 6
The American Society of Hypertension suggests considering minoxidil 2.5 mg two to three times daily (requires concomitant beta-blocker and loop diuretic) for severe refractory cases 1, 2, 5, 6